Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH AL 2018 | How have leukemia diagnostics and management evolved?

Elizabeth Macintyre • 4 May 2018
ESH AL 2018
Acute Lymphoblastic Leukemia Leukemia Imatinib

Elizabeth Macintyre, MD, PhD, of the Hôpital Necker-Enfants Malades, Paris, France, speaks about the advances made in leukemia diagnostics and therapeutics from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary.

More from Elizabeth Macintyre

European-wide MRD screening should be available for all
1:50
European-wide MRD screening should be available for all
Elizabeth Macintyre • 4 May 2018
How has MRD changed our ability to diagnose leukemia?
3:07
How has MRD changed our ability to diagnose leukemia?
Elizabeth Macintyre • 4 May 2018
The ALL frontier: should T-ALL be classed as a different disease?
1:17
The ALL frontier: should T-ALL be classed as a different disease?
Elizabeth Macintyre • 4 May 2018

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals